Affymetrix Launches Microarray Data Analysis Training University
News Oct 18, 2007
Affymetrix Inc. has announced the launch of Affymetrix University, a series of hands-on data analysis training courses that will be held in various locations throughout Europe and North America.
Affymetrix University courses provide biologists with a better understanding of how to design their microarray experiments with appropriate quality control, and how to apply statistical methods to interpret biological results effectively. The courses combine hands-on exercises with theoretical presentations and guest speaker seminars.
The first Affymetrix University course will focus on the analysis of gene expression levels using Affymetrix WT (Whole-Transcript) Exon Arrays and 3' IVT (In vitro Transcript) Expression Arrays. The first course will be held in High Wycombe, U.K., November 20-22, 2007. The second course will be held in Santa Clara, Calif., December 4-6, 2007.
Upcoming Affymetrix University data analysis courses will focus on the following microarray applications:
• Copy Number
• Exon/Alternative Splicing
• Integrated Genomic Approaches
“Affymetrix has launched Affymetrix University in response to a growing demand from our customers to help minimize the data analysis bottleneck. Affymetrix University provides an educational forum for biologists to learn more about the essential principles of data analysis involved in successful microarray experiments,” said Rob Clum, market development manager of informatics at Affymetrix.
“With these courses, we are enabling researchers to design studies and access biological data more effectively. This will accelerate research and enable our customers to publish faster than before.”
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.